Abstract
Lycopene (LYC) is a natural pigment present in tomatoes and other red fruits and vegetables including red carrots, red peppers, watermelons, pink grapefruits, apricots, pink guavas, and papaya. There is some evidence that LYC may provide protection against mutations induced by ionizing radiation. The study aimed to investigate whether the genetic material of reticulocytes (RET) could be protected from radiation-induced damage by LYC. Mice were treated with LYC [0.15 mg/kg bodyweight (bw), 0.30 mg/kg bw], acute and fractionated irradiation (0.5 Gy, 1 Gy applied daily), or with both agents (0.5 Gy + 0.15 mg/kg bw LYC, 0.5 Gy + 0.30 mg/kg bw LYC, 1 Gy + 0.15 mg/kg bw LYC, 1 Gy + 0.30 mg/kg LYC). LYC supplementation was started at 24 h or 1 week after the first irradiation. Irradiation significantly enhanced the frequency of micronuclei (MN) in RET. LYC treatment at a dose of 0.15 mg/kg bw 24 h after starting fractionated radiation at 1 Gy significantly decreased (41–68%, p < 0.0125) the level of MN in peripheral blood and bone marrow RET. LYC supplementation at 0.30 mg/kg bw did not significantly alter the frequency of MN in peripheral blood, but significantly increased the frequency of bone marrow RET MN. LYC treatment on day 8 following the first radiation exposure showed results similar (92–117%, p > 0.24) to those obtained with irradiation alone. Lycopene may act as a radiomitigator but must be administered at low doses and as soon as possible after irradiation. Contrary, combined exposure with high doses of irradiation and LYC may enhance the mutagenic effect of irradiation.
Similar content being viewed by others
Introduction
Ionizing radiation (IR) is continuously present in the natural environment and at various human workplaces. Natural background radiation comes from cosmic plus solar radiation and terrestrial radionuclides that occur in the Earth’s crust, building materials, air, water, food and the human body. The dose of naturally occurring radiation, i.e., the background effective dose is estimated to be ~ 2.4 mSv per year, and about 3 mSv including artificial sources (UNSCEAR 2008). IR may be emitted during the natural decay process of certain unstable nuclei, or following the excitation of atoms and their nuclei in nuclear reactions, cyclotrons, X-ray machines, and others including medical devices. Moreover, there are occupations where people are exposed to radiation such as airline crews; industrial radiography, medical radiology, and nuclear medicine staff; uranium mining workers; nuclear power plant and nuclear fuel reprocessing plant workers; and research laboratory employees (UNSCEAR 2008; Pattison et al. 1996; Pattison 1999; Hendry et al. 2009; Eisenbud 1987).
IR represents electromagnetic waves and particles that carry sufficient energy to ionize or remove electrons from an atom. Ionization provoked by radiation induces several chemical reactions leading to serious changes in atoms and molecules, which may thus lead to cell damage. There are two primary mechanisms of IR interactions with biological matter: direct effects owing to deposition of energy with a macromolecule, and indirect effects from the interaction of energy with water to produce reactive oxygen species (ROS) (Barcellos-Hoff et al. 2005). For both types of electromagnetic waves that can ionize atoms, i.e., X-rays and γ-rays, 60% of the damage is caused by indirect effects. The impact of IR is a function of the physical attributes of radiation type, dose, and whether the exposure is acute, fractionated, or chronic. Biological responses to radiation depend on the age, tissue type, genetic background, and physiological status of the exposed individual (Barcellos-Hoff et al. 2005 Desouky et al. 2015; Ward 1988).
Molecules with direct free-radical-scavenging properties are particularly promising in protection against radiation. The discovery of non-toxic modifiers/radioprotectors (agents which when present prior to or shortly after radiation exposure, alter the tissue responses to radiation) and/or radiomitigators (agents that may be used to minimize toxicity even when applied after radiation exposure) is very important for radiation protection of humans (Cirin et al. 2010). Dietary antioxidants may protect cells against DNA damage induced by endogenous and exogenous sources, including IR. Carotenoids are organic lipid-soluble pigments found in the chloroplasts and chromoplasts of plants (Krzyzanowska et al. 2010). Lycopene (LYC) is an acyclic isomer of β-carotene and a natural pigment, synthesized by plants and microorganisms. It is the main carotene present in tomatoes and other red fruits and vegetables including red carrots, red peppers, watermelons, pink grapefruits, apricots, pink guavas, and papaya (Islamian and Mehrall 2015). LYC concentrations in tomatoes range from 7.8 to 18.1 mg/100 g fresh weight (fw) (Martí et al. 2016), whereas in tomato paste, they range from 51 to 59.7 mg/100 g (Tonucci et al. 1995). LYC is one of the most potent antioxidants, with singlet oxygen-quenching ability twice as high as that of β-carotene and 10 times higher than that of α-tocopherol (Di Mascio et al. 1989).
The antioxidative, radioprotective and anticancer properties of LYC were reviewed by Gajowik and Dobrzyńska (2014). Evidence for the ability of lycopene to modulate ROS levels showed that it may chemically interact with ROS and undergo oxidation, thus preventing ROS-induced cell damage (Palozza et al. 2010). Previous studies have suggested that inclusion of LYC in diet can reduce the risk of cancer (Giovannucci 1999; Rao and Agarwal 2000) and cardiovascular diseases (Rao and Agarwal 2000; Rao 2002).
There is some evidence that LYC may provide protection against mutations induced by ionizing radiation. Numerous studies have shown the beneficial effect of LYC when administered before or during irradiation (Saada and Azab 2001; Srinivasan et al. 2007; 2009; Cavusoglu and Yalcin 2009; Saada et al. 2010). In contrast, there are few papers describing the effect of LYC administered after irradiation (Forssberg et al. 1959; Maydan et al. 2011).
The present study aimed to investigate whether protection of the genetic material of reticulocytes (RET) from damage expressed as radiation-induced micronuclei, could be achieved by co-administration of LYC at different times after irradiation.
Materials and methods
Animals and exposure to radiation and LYC
Seven-week-old male Swiss outbred laboratory mice obtained from the “Kołacz” Animal Breeding Laboratory (Warsaw, Poland) were housed in standard rodent cages in a room with controlled temperature, humidity, and light cycles (12 h dark, 12 h light). Tap water and rodent diet were available ad libitum. The mice were randomly assigned to either control or exposed groups, 1 week after acclimatization. LYC (ROTH cat. no: 1180.1, purity > 90%) was dissolved in 1 ml of DMSO and diluted in drinking water to obtain the desired dose. The concentration of DMSO in drinking water with LYC was less than 0.25%. 8-week-old male mice were exposed to LYC (0.15 mg/kg body weight (bw) or 0.30 mg/kg bw, daily), irradiation with X-rays (0.5 Gy or 1 Gy, daily), or a combination of both agents (0.5 Gy + 0.15 mg/kg bw LYC, 0.5 Gy + 0.30 mg/kg bw LYC, 1 Gy + 0.15 mg/kg bw LYC, 1 Gy + 0.30 mg/kg bw LYC daily). Animals were irradiated 5 times per week (working days), whereas LYC was continuously supplied in drinking water starting from 24 h or 1 week following the initiation of daily irradiation. Body weight of the animals was checked weekly, and the volumes of control water and LYC-water solution were checked daily. The solution of LYC in water was prepared twice a week. A therapeutic Roentgen unit Medicor type THX-250 (Hungary) was used for irradiation. It was operated with the following parameters: 155 kV, 18 mA, added filtration 0.25 mm Cu and HVL 2 mm Al. Mice were subjected to whole-body irradiation at the dose rate of 0.2 Gy/min. In the case of combined exposure, LYC supplementation was started at 24 h or 1 week (8th day) following initial radiation exposure (Fig. 1). Control animals were sham irradiated and unexposed to LYC, and mice exposed only to LYC. Mice from above groups and from the control group received tap water. Animals were killed 24 h after the last irradiation. Six to eight mice were used for each of the dose and time period. The total doses to mice where LYC supplementation started 24 h following radiation were 5 Gy or 10 Gy for irradiation, 1.95 mg/kg bw or 3.9 mg/kg bw for LYC, and 5 Gy + 1.95 mg/kg bw LYC, 5 Gy + 3.9 mg/kg bw LYC, 10 Gy + 1.95 mg/kg bw LYC, and 10 Gy + 3.9 mg/kg bw LYC for combined exposure. The total doses to mice where LYC supplementation started at 1 week following irradiation were 5 Gy or 10 Gy for irradiation, 1.05 mg/kg bw or 2.1 mg/kg bw for LYC, and 5 Gy + 1.05 mg/kg bw LYC, 5 Gy + 2.1 mg/kg bw LYC, 10 Gy + 1.05 mg/kg bw LYC, and 10 Gy + 2.1 mg/kg bw LYC for combined exposure.
The study was approved by the IV Local Ethical Commission for Animal Experiments.
Micronucleus test
For the micronucleus (MN) assay, blood samples were drawn from the caudal vein at 1 (day 8) and 2 weeks (day 15) after the first irradiation. Bone marrow samples were harvested from animals killed at 2 weeks after the treatment. Femoral bone marrow cells were aspirated with 3 ml fetal bovine serum. Cells were centrifuged at 800×g for 10 min, and after removing the majority of the supernatant, the pellet was resuspended. For examination of the MN in reticulocytes (RET), the method described by Hayashi et al. (1990) was adapted. Cells in suspension (25 µl) were dropped on microscope slides coated with acridine orange solution and immediately covered with a cover slip. Similarly, 10 µl of peripheral blood was dropped on a microscope slide coated with acridine orange solution followed by covering with a cover slip. Using a fluorescence microscope (Nikon, Japan), one thousand reticulocytes per animal were scored from the bone marrow and peripheral blood cells to calculate micronucleus frequencies. The MN-PCE frequencies were calculated as (total number of MN scored/1000 PCEs) × 100 and reported as MN-PCE% (mean pooled value for all mice in each group ± standard deviation.
Statistical analysis
The data were analyzed by one-way analysis of variance (ANOVA), with a post hoc Fisher test. The significance level was set at p < 0.05.
Results
The results of LYC supplementation beginning 24 h after the first irradiation on the MN frequency in mouse RET are shown in Table 1. At the beginning of the experiment the mean body weight of mice from the group exposed to 0.5 Gy of irradiation daily was significantly higher compared to control. The mean body weights of animals of groups 0.5 Gy + 0.15 mg/kg bw LYC, 1 Gy + 0.15 mg/kg bw LYC and 1 Gy + 0.30 mg/kg bw LYC were significantly lower compared to animals exposed to appropriate dose of irradiation. After 1 week of exposure, the body weights of animals of 1 Gy + 0.15 mg/kg bw LYC and 1 Gy + 0.30 mg/kg bw LYC were significantly lower compared to negative control and 1 Gy group alone. After 2 weeks of exposure, the mean body weights of animals of groups 0.5 Gy, 1 Gy, 0.5 Gy + 0.15 mg/kg bw LYC, 0.5 Gy + 0.30 mg/kg bw LYC, 1 Gy + 0.15 mg/kg bw LYC and 1 Gy + 0.30 mg/kg bw LYC were significantly decreased compared to control. In the case of group and 1 Gy + 0.30 mg/kg bw LYC the mean body weight was significantly higher compared to the group of 1 Gy alone.
Two weeks of LYC treatment with doses of 0.15 mg/kg bw or 0.30 mg/kg bw daily did not induce MN frequencies higher than those in control mice. Daily irradiation of animals with 0.5 Gy as well as 1 Gy induced a 7.5–27.5-fold increase in the frequency of MN in RET from both peripheral blood and bone marrow compared to the controls. Compared to radiation alone, LYC supplementation (0.15 mg/kg bw, 0.30 mg/kg bw) simultaneously with irradiation at a daily dose of 0.5 Gy did not change the frequency of MN in peripheral blood RET measured at 1 week post-irradiation in peripheral blood or in bone marrow RET measured at 2 weeks post-irradiation. LYC administration at 0.15 mg/kg bw beginning 24 h after irradiation with 1 Gy significantly decreased the level of radiation-induced MN in peripheral blood RET at the first week post-irradiation and in the bone marrow by the end of exposure, but not in peripheral blood after 2 weeks of treatment (Table 1). LYC supplementation at the dose of 0.30 mg/kg bw did not significantly change the frequency of radiation-induced MN in peripheral blood, but significantly increased the MN frequency in bone marrow RET after the end of 1 Gy exposure.
The effects of LYC supplementation on MN induction in mouse RET beginning on day 8 after the first irradiation are shown in Table 2. At the beginning of the experiment, the mean body weights of mice from groups 1 Gy and 1 Gy + 0.15 mg/kg bw LYC were significantly lower, whereas from group 0.15 mg/kg bw LYC was significantly higher as compared to controls. After 1 week of exposure, the mean body weight of animals from the 0.1 Gy group was significantly lower as compared to the control group. After 2 weeks of exposure the body weights of mice from groups 1 Gy, 1 Gy + 0.15 mg/kg bw LYC and 1 Gy + 0.30 mg/kg bw LYC were significantly reduced compared to control. Additionally, the mean body weight of animals from the group 1 Gy + 0.30 mg/kg bw LYC was significantly different compared to animals exposed to 1 Gy alone.
As mentioned above, LYC administration for 1 week did not induce MN frequencies higher than those of control mice. The frequencies of MN in peripheral blood and bone marrow RET were significantly increased in both irradiated groups. In mice receiving LYC supplementation at doses of 0.15 mg/kg bw and 0.30 mg/kg bw beginning from the second week of irradiation, the MN frequencies at the end of the second week in the combined groups (i.e., LYC + irradiation) were similar to those observed after irradiation alone.
Discussion
In the present study mice were exposed to a combination of fractionated X-radiation and LYC. Total doses of 5 Gy and 10 Gy applied within 2 weeks, i.e., 0.5 Gy and 1 Gy per day, were chosen for this study. According to the 2007 Recommendations of the International Commission on Radiological Protection, the effective dose for occupational exposure is recommended to be 20 mSv/year, averaged over 5-year periods (100 mSv in 5 years), with further provision that the effective dose should not exceed 50 mSv in a single year. Under unusual circumstances, the dose for such exposure is enhanced to 100 mSv (Annals of the ICRP 2007). Based on the precautionary principle, a factor of 10 is typically applied when extrapolating results on radiation-induced health effects from animal models to humans (Calabrese and Cook 2005). Also, a factor of 10 is applied to account for intra-individual variability in a population (Calabrese and Cook 2005). In this way, 50 mSv × 10 × 10 = 5 Sv and 100 mSv × 10 × 10 = 10 Sv. Given the fact that for X-rays and gamma rays, the equivalent dose of 1 Sv = 1 Gy and that mice were whole-body irradiated, it can be assumed that the total doses of 5 Gy and 10 Gy chosen in this animal study correspond to effective doses to humans of 50 mSv and 100 mSv, respectively, given in a short period of time.
The majority of commercially available diet supplements contain LYC at concentrations of 10 or 20 mg per tablet. For adult people weighing approximately 70–75 kg, 1 tablet corresponds to a dose of approximately 0.15 mg/kg bw or 0.30 mg/kg bw, respectively. Therefore, these doses were used in our study. We observed that one mouse drinks approximately 7 ml of water daily. We thus calculated the LYC concentration in the water for each mouse based on the above volume and its body weight. Whole-body irradiation and LYC exposure in drinking water (consumption) were chosen because these routes are the most frequent routes for human treatment.
Exposure to ionizing radiation, depending on the total dose, dose rate, and species may cause damage to living tissues, leading to induction of mutations, cancer, or cell death. In the case of lethal mutations, potentially dangerous cells are eliminated from the organism (Rodriguez-Rocha et al. 2011). Misrepaired damage may result in chromosomal damage or mutations, or cause acute adverse effects within hours to weeks or delayed effects within months to years after exposure. The resulting modification may be transmitted to further generations of cells and may eventually lead to cancer (Elmore et al. 2006; Sowa et al. 2006; Suit et al. 2007; Rodriguez-Rocha et al. 2011). IR may damage cells of the bone marrow by exhaustion of stem cells, progenitor cells, and precursor cells or by inducing genotoxic effects (Sun et al. 2011). IR induces oxidative stress through ROS generation resulting in the imbalance of pro-oxidants and antioxidants in cells (Atessahin et al. 2006).
Formation of micronuclei is associated with cytogenetic damage induced by clastogenic agents that cause disruption or breakage of chromosomes, leading to sections of the chromosome being deleted, added, or rearranged, or by aneugenic agents that interfere with the mitotic spindle apparatus (Yamamoto and Kikuchi 1980; Rosefort et al. 2004). In the present study, fractionated doses of 0.5 and 1 Gy administered to mice for 1 or 2 weeks induced MN both in the bone marrow and in peripheral blood RET. Induction of micronuclei in reticulocytes or polychromatic erythrocytes in mouse bone marrow or peripheral blood in vivo following irradiation were also observed previously at different doses and times of irradiation (Gandhi 2013; Bannister et al. 2016; Dobrzyńska et al. 2016). The frequency of micronuclei was similar for 0.5 Gy and lower for 1 Gy as compared to our earlier study, where the same doses of irradiation were used (Dobrzyńska et al. 2016).
LYC was administered in an all-trans form, which is its natural, stable form. LYC is unstable when exposed to light, heat, and oxygen. To prevent isomerization and oxidation, synthetic lycopene is kept under inert gas in lightproof containers and stored in a cool place (FAO 2006). The results of Nishino et al. (2013) showed that the stability of lycopene in aqueous solution was influenced by the type and amount of emulsifier used. Therefore, LYC was dissolved in DMSO, which extended its stability. The results of the present study confirmed previous results demonstrating that lycopene alone is not genotoxic, and does not induce MN in RET of the peripheral blood and bone marrow in mice in vivo (Velmurugan et al. 2004; Banji et al. 2013).
Pre-treatment of irradiated mice with tomato extract resulted in a significant reduction of chromosomal aberration frequency in the bone marrow in vivo (Dhirhe et al. 2011). Based on a study on consumption of tomatoes and tomato puree, Riso et al. (1999) suggested that consumption of tomato products may reduce the susceptibility of lymphocyte DNA to oxidative damage. In the case of LYC pre-treatment, irradiated lymphocytes are protected against DNA damage via decreased lipid peroxidation leading to improved antioxidant status (Wertz et al. 2004). It was postulated that during singlet oxygen quenching, energy is transferred from the singlet oxygen to the LYC molecule, converting it to an energy-rich triplet state (Wertz et al. 2004). Pre-treatment with 1, 5, and 10 µg/ml LYC in drinking water significantly decreased the frequency of radiation-induced (at doses of 1 Gy, 2 Gy and 4 Gy) MN and chromosomal aberrations in cultured human lymphocytes in vitro as compared to γ-irradiation alone (Srinivasan et al. 2009). Similarly, pre-treatment of human lymphocytes in vitro with various concentrations of LYC (10, 20, 40 µM/ml) directly and 1 h before irradiation with 1 Gy or 2 Gy decreased the DNA damage compared to the cells irradiated alone (Gajowik and Dobrzyńska 2017). LYC administration before diagnostic radiation exposure might be, therefore, useful to prevent damage to normal cells of cancer patients.
In the present study, only LYC at 0.15 mg/kg bw administered with a 24-h delay following radiation exposure mitigated the effect of irradiation at a dose of 1 Gy, both in peripheral blood and bone marrow RET. In contrast, a higher dose of 0.30 mg/kg bw LYC combined with irradiation induced a slightly increased level of MN in the bone marrow. In the case of 0.5 Gy radiation dose, the results of combined exposure were not significantly different compared to those of irradiation alone. No effects on MN frequency were observed in the case of LYC administration initiated on the eighth day following the first radiation exposure. These results imply that only the lower dose of LYC is protective against damage up to a certain level of fractionated radiation exposure, demonstrating a potential radiation threshold for protection. Generally, application of LYC before irradiation seems to be more beneficial, but not always is its effect on the radiation effect predictable. This study also analyzed the impact of LYC supplementation after the start of irradiation. Ability of LYC to decrease radiation-induced damage might be useful in the case of radiological accidents as well as possibly for radiological protection of non-treated tissues of cancer patients.
The LYC doses in the current paper are based on the daily intake that people may consume via dietary supplements (0.15 or 0.30 mg/kg bw, which corresponds to 10.5 or 20.1 mg/day for adults weighing 70 kg). The average daily intake of LYC in the United States ranges from 6.6 to 10.5 mg/day for men and from 5.7 to 10.4 mg/day for women, whereas in the United Kingdom it is 1.1 mg/day, in Spain 1.6 mg/day, in Australia 3.8 mg/day, in France 4.8 mg/day, and 4 in the Netherlands 9 mg/day (Porrini and Riso 2005). Based on the results of the present study, it may be concluded that the intake level of LYC may be sufficient to reduce radiation effects among US citizens, but too low for inhabitants of Europe and Australia.
It is well-established that the antioxidant properties of carotenoids are related to their radical scavenging properties as well as their exceptional singlet oxygen-quenching abilities (Conn et al. 1991; Hill et al. 1995; Everett et al. 1996; Mortensen and Skibsted 1996). As reported previously, in addition to antioxidant properties, carotenoids can also act as pro-oxidants, especially at higher concentrations (Miller et al. 1996; Martin et al. 1999; El-Agamey et al. 2004). The related antioxidant/prooxidant properties are likely to depend on factors like the rate of scavenging different types of radicals, the mode of reaction, and the properties of the resulting carotenoid radicals (Everett et al. 1996; Martin et al. 1999; Rice-Evans et al. 1997). The above finding may explain our results, where a dose of 0.15 mg/kg bw LYC applied with a 24-h delay mitigated the induction of MN by 1 Gy, whereas a higher dose, i.e., 0.30 mg/kg bw LYC, significantly enhanced the induction of MN. Young and Lowe (2001) proposed that the decreased antioxidant effect is due to carotenoid aggregation. Another explanation is a faster rate of carotenoid anti-oxidation (Palozza 1998). Forssberg et al. (1959) reported a moderate curative action (protection from lethal bacterial infection) with an increased survival rate with LYC administration both before and after X-ray irradiation in cancer-bearing mice in vivo. In an in vitro study, Cavusoglu and Yalcin (2009) observed a protective effect of LYC on radiation-induced chromosomal aberrations in lymphocytes when applied before irradiation. Moreover, DNA damage induced in human lymphocytes with H2O2 in vitro was significantly reduced after the subjects consumed a tomato-rich diet (Duthie et al. 1996; Viuda-Martos et al. 2014). Similarly, the frequency of MN induced in polychromatic erythrocytes of bone marrow of mice in vivo by benzo[a]pyrene or cyclophosphamide was significantly reduced by LYC (Rauscher et al. 1998).
As shown in previous in vivo studies, LYC may protect cells against radiation toxicity, predominantly through an antioxidant pathway (Srinivasan et al. 2007, 2009; Andic et al. 2009; Saada et al. 2010; Meydan et al. 2011). Srinivasan et al. (2009) showed that pre-treatment with LYC protects lymphocytes from γ-radiation-induced damage by inhibiting the peroxidation of free radicals and DNA strand breaks. Jomova et al. (2012) noted that LYC at a concentration of 30 µg/g (i.e., 30 mg/kg) acts as a prooxidant. LYC significantly decreased the level of thiobarbituric acid-reactive substances (TBARS) induced by ferric nitrilotriacetate (Fe/NTA), but enhanced the level of TBARS induced by a lipid-soluble radical generator (2,2-azobis[2,4-dimethylvaleronitrile]) (AMVN) (Yeh and Hu 2000).
In conclusion, our study showed that lycopene may act as a radiomitigator but only when applied at a low concentration 24 h, but not 8 days after irradiation. LYC may be used in clinical practice to protection of healthy tissues of radiology patients as well as in the case of radiological emergency. Contrary, combined exposure with high doses of irradiation and LYC may enhance the mutagenic effect of irradiation.
References
Andic F, Garipagaoglu M, Yurdakonar E, Tuncel N, Kucuk O (2009) Lycopene in the prevention of gastrointestinal toxicity of radiotherapy. Nutr Cancer 61(5):784–788
Annals of the ICRP (2007) The 2007 recommendations of the international commission on radiological protection, vol 37, issue 2–4. ICRP Publication 103
Ateşşahin A, Karahan I, Turk G, Gur S, Yilmaz S, Ceribaşi AO (2006) Protective role of lycopene on cisplatin-induced changes in sperm characteristics, testicular damage and oxidative stress in rats. Reprod Toxicol 21(1):42–47
Banji D, Banji OJF, Reddy M, Annamalai AR (2013) Impact of zinc, selenium and lycopene on capsaicin induced mutagenicity and oxidative damage in mice. J Trace Elem Med Biol 27(3):230–235
Bannister LA, Mantha RR, Devantier Y, Petoukhov ES, Brindeau CL, Serran ML, Kiokov DY (2016) Dose and radioadaptive response analysis of micronucleus induction in mouse bone marrow. Int J Mol Sci 17(9):1548
Barcellos-Hoff MH, Park C, Wright EG (2005) Radiation and the microenvironment—tumorigenesis and therapy. Natl Rev Cancer 5(11):867–875
Calabrese EJ, Cook RR (2005) Hormesis: how it could affect the risk assessment process. Hum Exp Toxicol 24:265–270
Cavusoglu K, Yalcin E (2009) Radioprotective effect of lycopene on chromosomal aberrations (CAs) induced by gamma radiation in human lymphocytes. J Environ Biol 30(1):113–117
Cirin D, Cotrim AP, Hyodo F, Baum BJ, Krishna BJ, Mitchell JB (2010) Radioprotectors and mitigators of radiation-induced normal tissue injury. Oncologist 15(4):360–371
Conn PF, Schalch W, Truscott TG (1991) The singlet oxygen and carotenoid interaction. J Photochem Photobiol, B 11(1):41–47
Desouky O, Ding N, Zhou G (2015) Targeted and non-targeted effects of ionizing radiation. J Radiat Res Appl Sci 8:247–254
Dhirhe T, Maheshwari BK, Raut P, Dhirhe S (2011) Radio-protective effect of lycopersicon esculentum extract against radiation induced chromosomal aberration in swiss albino mice. Int J Pharm Sci Rev Res 7(1):97–99
Di Mascio P, Kaiser S, Sies H (1989) Lycopene as the most effective biological carotenoid singlet oxygen quencher. Arch Biochem Biophys 274(2):532–538
Dobrzyńska MM, Gajowik A, Radzikowska J (2016) The effect of in vivo resveratrol supplementation in irradiated mice on the induction of micronuclei in peripheral blood and bone marrow reticulocytes. Mutagenesis 31(4):393–399
Duthie SJ, Ma A, Ross MA, Collins AR (1996) Antioxidant supplementation decreases oxidative DNA damage in human lymphocytes. Cancer Res 56(6):1291–1295
Eisenbud M (1987) Environmental radioactivity: from natural, industrial and military sources, 3rd edn. Academic Press inc, San Diego
El-Agamey A, Lowe GM, McGarvey DJ, Mortensen A, Phillip DM, Truscott TG, Young AJ (2004) Carotenoid radical chemistry and antioxidant/pro-oxidant properties. Arch Biochem Biophys 430(1):37–48
Elmore E, Lao X-Y, Kapadia R, Redpath LH (2006) The effect of dose rate on radiation induced neoplastic transformation in vitro by low doses of low-LET radiation. Radiat Res 166(6):832–838
Everett SA, Dennis MF, Patel KB, Maddix S, Kundu SC, Wilson RL (1996) Scavenging of nitrogen dioxide, thiyl, and sulfonyl free radicals by the nutritional antioxidant β-carotene. J Biol Chem 271(8):3988–3994
FAO (2006) Lycopene (synthetic) chemical and technical assessment (CTA). http://www.fao.org/fileadmin/templates/agns/pdf/jecfa/cta/67/lycopene
Forssberg A, Lingen C, Ernste L, Lindberg O (1959) Modification of the X-irradiation syndrome by lycopene. Exp Cell Res 16(1):7–14
Gajowik A, Dobrzyńska MM (2014) Lycopene–antioxidant with radioprotective and anticancer properties: a review. Rocz Panstw Zakl Hig 65(4):263–271
Gajowik A, Dobrzyńska MM (2017) The evaluation of protective effect of lycopene against genotoxic influence of X-irradiation in human blood lymphocytes. Radiat Environ Biophys 56:413–422
Gandhi NM (2013) Baicalein protects mice against radiation-induced DNA damages and genotoxicity. Mol Cell Biochem 379(1–2):277–281
Giovannucci E (1999) Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature. J Natl Cancer Inst 91(4):317–331
Hayashi M, Morita T, Kodama Y, Sofuniand T, Ishidate MJR (1990) The micronucleus assay with mouse peripheral blood reticulocytes using acridine orange-coated slides. Mutat Res 245(4):245–249
Hendry JH, Simon SL, Wojcik A, Sohrabi M, Burkart W, Cardis E, Laurier D, Tirmarche M, Hayata I (2009) Human exposure to high natural background radiation: what can it teach us about radiation risks? J Radiol Prot 29:A29–A42
Hill TJ, Land EJ, McGarvey DJ, Schalch W, Tinkler JH, Truscott TG (1995) Interactions between carotenoids and the CC3O2.bul. radical. J Am Chem Soc 117(32):8322–8326
Islamian JP, Mehrall H (2015) Lycopene as a carotenoid provides radioprotectant and antioxidant effects by quenching radiation-induced free radical singlet oxygen: an overview. Cell J 16(4):386–391
Jomova K, Lawson M, Gala L (2012) Prooxidant effect of lycopene on triglyceride oxidation. J Microbiol Biotechnol Food Sci 1(February Special Issue):942–948
Krzyzanowska J, Czubacka A, Oleszek W (2010) Dietary phytochemicals and human. Adv Exp Med Biol 698:74–98
Martí R, Roselló S, Cebolla-Cornejo J (2016) Tomato as a source of carotenoids and polyphenols targeted to cancer prevention. Cancers (Basel) 8(6):58
Martin H-D, Jäger C, Ruck C, Schmidt M, Walsh R, Paust J (1999) Anti- and prooxidant properties of carotenoids. Adv Synth Catal 341(3):302–308
Meydan D, Gursel B, Bilgici B, Can B, Ozbek N (2011) Protective effect of lycopene against radiation-induced hepatic toxicity in rats. J Int Med Res 39(4):1239–1252
Miller NJ, Sampson J, Candeias LP, Bramley PM, Rice-Evans CA (1996) Antioxidant activities of carotenes and xanthophylls. FEBS Lett 384(3):240–242
Mortensen A, Skibsted LH (1996) Kinetics of parallel electron transfer from β-carotene to phenoxyl radical and adduct formation between phenoxyl radical and β-carotene. Free Radic Res 25(6):515–523
Nishino M, Sakata M, Murata Y, Nakamura Y (2013) Effects of emulsifiers on the photostability of lycopene. Food Sci Technol Res 19(6):983–987
Palozza P (1998) Prooxidant actions of carotenoids in biologic systems. Nutr Rev 56(9):257–265
Palozza P, Parrone N, Catalano A, Simone R (2010) Tomato lycopene and inflammatory cascade: basic interactions and clinical implications. Curr Med Chem 17(23):2547–2563
Pattison JE (1999) Finger doses received during Samarium-153 injections. Health Phys 77(5):530–535
Pattison JE, Bachmann DJ, Beddoe A (1996) Gamma dosimetry at surfaces of cylindrical containers. J Radiol Prot 16(4):249–261
Porrini M, Riso P (2005) What are typical lycopene intakes? J Nutr 135(8):2042S–2045S
Rao AV (2002) Lycopene, tomatoes, and the prevention of coronary heart disease. Exp Biol Med (Maywood) 227(10):908–913
Rao AV, Agarwal S (2000) Role of antioxidant lycopene in cancer and heart diseases. J Am Coll Nutr 19(5):563–569
Rauscher R, Edenharder R, Platt KL (1998) In vitro antimutagenic and in vivo anticlastogenic effects of carotenoids and solvent extracts from fruits and vegetable rich in carotenoids. Mutat Res 413(2):129–142
Rice-Evans CA, Sampson J, Bramley PM, Holloway DE (1997) Why do we expect carotenoids to be antioxidants in vivo? Free Radic Res 26(4):381–396
Riso P, Pinder A, Santangelo A, Porini M (1999) Does tomato consumption effectively increase the resistance of lymphocyte DNA to oxidative damage? Am J Clin Nutr 69(4):712–718
Rodriguez-Rocha H, Garcia-Garcia A, Panayiotidis MI, Franco R (2011) DNA damage and autophagy. Mutat Res 711(1–2):158–166
Rosefort C, Fauth E, Zankl H (2004) Micronuclei induced by aneugens and clastogens in mononucleate and binucleate cells using cytokinesis block assay. Mutagenesis 19(4):277–284
Saada HN, Azab KS (2001) Role of lycopene in recovery of radiation induced injury to mammalian cellular organelles. Pharmazie 56(3):239–241
Saada HN, Rezk RG, Eltahawy NA (2010) Lycopene protects the structure of the small intestine against gamma-radiation-induced oxidative stress. Phytother Res 24(Suppl. 2):S204–S208
Sowa M, Arthurs BJ, Estes BJ, Morgan WF (2006) Effects of ionizing radiation on cellular structure, induced instability and carcinogenesis. EXS 96:293–301
Srinivasan M, Sudheer AR, Pillai KR, Kumar PR, Suhakaran PR, Menon VP (2007) Lycopene as a natural protector against γ-radiation induced DNA damage, lipid peroxidation and antioxidant status in primary culture of isolated rat hepatocytes in vitro. Biochim Biophys Acta 1770(4):659–665
Srinivasan M, Devipriya N, Kalpana KB, Menon VP (2009) Lycopene: an antioxidant and radioprotector against γ-radiation-induced cellular damages in cultured human lymphocytes. Toxicology 262(1):43–49
Suit H, Goldberg S, Niemierko A, Ancukiewicz M, Hall E, Goitein M, Wong W, Paganetti H (2007) Secondary carcinogenesis in patients related with radiation: a review of data on radiation-induced cancers in human, non-human primate, canine and rodent subjects. Radiat Res 167(1):12–42
Sun H, Tsai Y, Nowak I, Dertinger SD, Wu JHD, Chen Y (2011) Response kinetics of radiation induced micronucleated reticulocytes in human bone marrow culture. Mutat Res 718(1–2):38–43
Tonucci LH, Holden JM, Beecher GR, Khachik F, Davis CS, Mulokozi G (1995) Carotenoid content of thermally processed tomato-based food products. J Agric Food Chem 43(3):579–586
UNSCEAR United Nations Scientific Committee on the Effects of Atomic Radiation (2008) Sources of ionizing radiation. Report of general assembly with annexes. United Nations Publication, New York
Velmurugan B, Santhiya ST, Nagini S (2004) Protective effect of S-allylcysteine and lycopene in combination against N-methyl-N′-nitro-N-nitrosoguanidine-induced genotoxicity. Pol J Pharmacol 56(2):241–245
Viuda-Martos M, Sanchez-Zapata E, Sayas-Barbera E, Sendra E, Perez-Alvarez JA, Fernandez-Lopez J (2014) Tomato and tomato by products. Human benefits of lycopene and its application to meat products: a review. Crit Rev Food Sci Nutr 54(8):1032–1049
Ward JF (1988) DNA damage produced by ionizing radiation in mammalian cells: identities, mechanisms of formation, and repair ability. Prog Nucl Acid Res Mol Biol 35:95–125
Wertz K, Siler V, Goraloczyk R (2004) Lycopene: modes of action to promote prostate health. Arch Biochem Biophys 430(1):127–134
Yamamoto KI, Kikuchi Y (1980) A comparison of diameters of micronuclei induced by clastogens and spindle poison. Mutat Res 71(1):127–131
Yeh S, Hu M (2000) Antioxidant and pro-oxidant effects of lycopene in comparison with β-carotene on oxidant-induced damage in Hs68 cells. J Nutr Biochem 11(11–12):548–554
Young AJ, Lowe GM (2001) Antioxidant and prooxidant properties of carotenoids. Arch Biochem Biophys 385(1):20–27
Acknowledgements
This work was supported by the National Institute of Public Health - National Institute of Hygiene, Warsaw, Poland as Scientific Project No. 12/ZŚ1/2015.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Disclosure of potental conflict of interest is enclosed.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
Dobrzyńska, M.M., Gajowik, A. & Radzikowska, J. The effect of lycopene supplementation on radiation-induced micronuclei in mice reticulocytes in vivo. Radiat Environ Biophys 58, 425–432 (2019). https://doi.org/10.1007/s00411-019-00795-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00411-019-00795-0